N Anthony Coles insider trades
Open-market stock purchases and sales by N Anthony Coles, Director at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 31, 2010.
Companies traded
- REGN Regeneron Pharmaceuticals, Inc: 32 sales, last Jan 2, 2026
- CERE Cerevel Therapeutics Holdings, Inc: 28 sales, last Aug 1, 2024
- YMTX Yumanity Therapeutics, Inc: other filings, last Apr 1, 2021
- MCK McKesson Corp: 2 sales, last Aug 17, 2020
- CRSP CRISPR Therapeutics AG: other filings, last May 31, 2017
- ONXX Onyx Pharmaceuticals Inc: 20 sales, last Oct 1, 2013
- CCG Campus Crest Communities, Inc: other filings, last Apr 22, 2013
- LH Laboratory Corp of America Holdings: other filings, last Feb 15, 2013